SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company

SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera") ...
InvestorsHub on MSN

SciSparc advances quantum clinical data analytics as NeuroThera validates proprietary computing platform

NeuroThera completed internal validation of a quantum-enabled workflow designed to enhance clinical trial data analysis, ...

NeuroThera Labs Advances Its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 Company

Company Validates Proprietary Quantum Sampling Workflow, Enabling Representations of Continuous Clinical Data Within a Quantum Computing Framework TORONTO, ONTARIO - July 29, 2026 (NEWMEDIAWIRE) - ...

SciSparc Ltd: SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company

SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical ...